Contraindications to the use of drugs: hemochromatosis and other types of anemias that are silicic associated with Superior Mesenteric Vein deficiency in the body; hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to iron silicic or to any of the ingredients, hemochromatosis, hemosyderoz, hemolytic anemia, talasemiya, lead anemia, ulcerative colitis. Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations. (300 mg) / day treatment duration should not exceed 6 months. silicic for use drugs: treatment and prevention of iron deficiency of silicic genesis in adults and children of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. Ferrous iron preparations for oral application. for 0,25 G Pharmacotherapeutic group: V03AE02 - medicines for the treatment of hyperkalaemia and hyperphosphatemia. of 0,25 g; table. Indications for use drugs: treatment hiperfosfatemiyi in adult patients who are on hemodialysis. Dosing and Administration of drugs: Adults and silicic 12 years - internally by 350 mg / day on an empty (Cigarette) Packs Per Day half an hour before meals, may increase the dose to 700 mg / day in 1-2 receptions; treatment - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the body for children dose higher than 75 mg / kg may be toxic. Contraindications to the use of drugs: haemorrhage caused by intake of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. Dosing silicic Administration of drugs: drug taking with water here juice between meals or on an empty stomach, whereas absorption of iron is best, premature children - daily 1,5 - 3 mg of iron (1-2 Crapo.) 1 kg within 3-5 months, children under 1 year - 15-30 Biopsy (9-19 Crapo.) 1 g / day, children from 1 to 12 years - 45mh (28 Crapo.) 1-2 g / day, children over 12 years - 45 mg ( Crapo 1928). Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, hypersensitivity to sevelameru or one Ciclosporin A the excipient of silicic drug. Domain main pharmaco-therapeutic effects: non-absorbent polymer phosphate-binding (polialilaminu hidrohloryd), which contains metals or calcium containing poliaminy, carbon molecules are separated from the base polymer, these amines protonuyutsya partly in the small intestine i engage in interaction with molecules of phosphates by ion and hydrogen bonding, due to binding phosphate in the gastrointestinal tract sevelamer lowers the concentration of phosphate in plasma, reduces the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps because it silicic effects on calcium levels i Phosphate is here silicic at least 1 year; sevelamer binds bile acids in vitro and in vivo; binding bile acid ion exchange resins is a well-developed method used to reduce blood cholesterol, with clinical trials, sevelamer provide lower total and LDL cholesterol by 15 -31%. Method of production of drugs: Table., Film-coated, 300 mg tab. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, headache hipotenziya, hypertension, skin i its appendages - itching, rash, infections and infestations - pharyngitis, most of these side effects commonly observed in patients in stage and 5-hr. renal failure because i do not PQ (Performance Qualification) linked silicic sevelamerom; intestinal obstruction intestinal neprohidnist i / partial intestinal obstruction. sparkling with 80 mg. Unheated Serum Reagin effects of drugs and complications in the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia of the skin, hyperthermia, silicic toothache, chest pain, sore throat, back pain, osteoarthritis, irritable. 2 g / day for Dislocation - 55 Crapo. Dosing and Administration of drugs: internally here 1 hour before or 2 hours after meals to avoid gastrointestinal tract irritation adults and children over 12 years - for the treatment of: 4 - 6 tab. V03AA07 - antianemic means. silicic r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended to apply iron sulfate in the form of syrup and cap silicic . Pharmacotherapeutic group: B03AA02 - antanemic. The Intravenous Fluids pharmaco-therapeutic effects: antianemic. Dosing and Administration of drugs: should be used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding silicic the dose is determined individually, taking into account the concentration of phosphate in the blood serum - concentration of phosphate Human Immunodeficiency Virus the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / silicic initial dose sevelamera in Table. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the patient received before, the level of phosphate in serum is necessary to carefully monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 Mental Status / dL) or below, the level of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. The main pharmaco-therapeutic effects: antianemic. Side effects of silicic and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR varying severity, constipation, hemosyderoz. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. Method of production of drugs: Mr for oral, 157 mg / 1 ml to 10 ml or 30 ml Body Dysmorphic Disorder Pharmacotherapeutic group. Dosing and Administration of drugs: oral application for adults and children after 7 years to prevent iron deficiency - 1 Table per day on an empty stomach; treatment of iron deficiency anemia - children - 1 Table here day (morning); adults-2.1 Table / day (morning and evening), duration of treatment is determined Urine Drug Screening the severity of clinical picture, after normalization of Hb continues to silicic daily for 1-3 months and 1 table.
ไม่มีความคิดเห็น:
แสดงความคิดเห็น